Certara acquired Drug Interaction Database (DIDB), University of Washington for $8.3 million, a transaction completed in June 2023, structured as asset purchase (all cash).
Drug Interaction Database (DIDB), University of Washington operates in Data / Software, is based in United States (University of Washington). Through an asset purchase agreement with the University of Washington, Certara acquired the Drug Interaction Database (DIDB) and related products - a curated database of drug-drug interaction data used in clinical pharmacology and regulatory science. Total estimated consideration was approximately $8.34 million. The acquisition deepened the proprietary data underpinning Certara's biosimulation and drug-interaction offerings.
Acquire proprietary drug-interaction data assets to support Certara's biosimulation and clinical-pharmacology software.
Advisory firms were not disclosed for this transaction.